Latest Breaking News On - Dnastar inc - Page 6 : vimarsana.com
Global Bioinformatics Markets & Technologies Report 2021-2025: Antibody-Based Drug Discovery and Development, Development of Novel Bioinformatics and Drugs, New Antibody Technologies & Antibody Types
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Bioinformatics Markets & Technologies Report 2021-2025: Antibody-Based Drug Discovery and Development, Development of Novel Bioinformatics and Drugs, New Antibody Technologies & Antibody Types
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share:
ResearchAndMarkets.com s offering.
The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.
The high growth rate of this segment is attributed to factors such as the demand for antibodies research, the expanding COVID-19 pandemic, epidemics of other infectious diseases, and an increase in R&D activities by key companies to develop new data regarding genetic consequences to counter the rise in different infectious diseases globally.
Moreover, the advancement of biological discoveries will result in the need for more molecular targets to be detected by their antibodies and the usage of different bioinformatic tools. For example, publicly available datasets of human BCR were selected to represent different sequencing platforms such as Illumina MiSeq, Roche 454, and Ion Torrent.
Share this article
Share this article
ResearchAndMarkets.com s offering.
Amid the COVID-19 crisis, the global market for Metagenomic Sequencing estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 15.9% over the analysis period 2020-2027.
Reagents & Consumables, one of the segments analyzed in the report, is projected to record a 16.7% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 15.8% CAGR for the next 7-year period.
vimarsana © 2020. All Rights Reserved.